Opioid use disorder can affect every part of a person’s life, from physical health and daily responsibilities to relationships, safety, and hope for the future. While recovery may feel hard to imagine when withdrawal symptoms and cravings are constant, evidence-based medications can make treatment safer and more manageable.
Suboxone is a medication used to treat opioid use disorder. It combines buprenorphine and naloxone, two medications that work together to reduce opioid withdrawal symptoms and cravings while lowering the risk of misuse when taken as prescribed.1, 2 Because buprenorphine is a partial opioid agonist, it activates opioid receptors differently than heroin, fentanyl, or prescription opioids, which means it can ease withdrawal without producing the same full opioid effect.1
At Painted Grove Recovery in Louisville, KY, Suboxone may be used as part of a medically supervised medication-assisted treatment (MAT) program. Since medication works best when it is paired with counseling, structure, and ongoing recovery support, our team helps each client understand how Suboxone fits into a broader plan for healing.
This guide explains what Suboxone is, how it works, how it compares to Subutex and methadone, what to expect during Suboxone treatment, and how Painted Grove Recovery supports people through every phase of care.
Speak with a recovery specialist today.
Suboxone medication contains two active ingredients: buprenorphine and naloxone. Because these medications serve different purposes, understanding each one can help people feel more informed before starting treatment.
Buprenorphine is a partial opioid agonist. It binds to opioid receptors in the brain and helps reduce withdrawal symptoms and cravings, although it does not activate those receptors as strongly as full opioid agonists such as heroin, fentanyl, oxycodone, or methadone.1 This partial effect is one reason buprenorphine can support recovery without creating the same full opioid high when taken as prescribed.
Buprenorphine also has a ceiling effect. After a certain point, increasing the dose does not continue to increase opioid effects in the same way that full opioid agonists do. While buprenorphine still requires careful medical supervision, this ceiling effect helps reduce the risk of respiratory depression compared with full opioid agonists.1
Naloxone is an opioid antagonist. In Suboxone, naloxone is included to discourage misuse. When Suboxone is taken correctly as a sublingual medication, naloxone has a limited effect. However, if someone dissolves and injects the medication, naloxone may trigger sudden withdrawal in a person who is physically dependent on opioids.1, 2
Suboxone is available as a sublingual film, sometimes called Suboxone strips, and in tablet form. Because sublingual buprenorphine is absorbed through the tissues in the mouth, the medication must dissolve under the tongue or inside the cheek as directed by a prescribing clinician.2
For those who are looking into opioid use disorder treatment, Suboxone may help create enough physical stability to participate more fully in therapy, group support, and recovery planning.
Suboxone and Subutex both contain buprenorphine, but they are not the same medication. Suboxone contains buprenorphine and naloxone, while Subutex contains buprenorphine only.1
The naloxone in Suboxone is added as a misuse deterrent. Since naloxone may trigger withdrawal if the medication is injected, the combination product helps reduce the risk of misuse while still allowing buprenorphine to treat cravings and withdrawal when taken as prescribed.1, 2
Subutex, or buprenorphine monotherapy, may be considered in certain clinical situations. For example, some clinicians may use buprenorphine-only medication during early induction, during pregnancy, or when a person has a documented sensitivity to naloxone. These decisions depend on medical history, withdrawal status, pregnancy status, medication response, and provider judgment.
Painted Grove Recovery offers information and care related to Subutex when buprenorphine monotherapy is clinically appropriate.
People also ask about Suboxone vs. methadone. While both medications treat opioid use disorder, they work differently. Methadone is a full opioid agonist, while buprenorphine is a partial opioid agonist.1 Methadone treatment is typically provided through federally regulated opioid treatment programs, while buprenorphine products such as Suboxone may be prescribed by qualified clinicians in office-based or treatment program settings.1, 3
Neither medication is “better” for every person. Since each has different benefits, risks, access considerations, and monitoring needs, the right choice depends on a clinical assessment and the person’s treatment goals.
Suboxone dosage is not one-size-fits-all. A licensed prescribing clinician determines the appropriate dose based on a person’s opioid use history, withdrawal symptoms, medical needs, response to medication, and recovery goals.
Suboxone treatment often begins with induction. During Suboxone induction, the medication is usually started when mild-to-moderate opioid withdrawal symptoms are already present.1 This timing matters because starting buprenorphine too soon after using opioids may trigger precipitated withdrawal, which is a sudden and uncomfortable worsening of withdrawal symptoms.
Because induction requires careful timing, medical supervision is important. A clinician may assess symptoms, confirm that withdrawal has started, and then adjust medication based on how the person responds.
Suboxone forms may include:
Both film and tablets are designed to dissolve in the mouth. Since swallowing the medication too early can reduce absorption, patients should follow their clinician’s instructions carefully.
After induction, the dose may be adjusted through a process called titration. During titration, the clinician monitors withdrawal symptoms, cravings, side effects, sedation, and overall stability. The goal is not to use the highest dose possible. The goal is to find the safest effective dose that supports recovery.
Suboxone may be used short-term or longer-term, depending on the person’s needs. Some people use Suboxone during detox or early stabilization, while others benefit from Suboxone maintenance as part of ongoing opioid addiction treatment.
Because opioid use disorder is a chronic medical condition for many people, longer treatment with medication may reduce relapse and overdose risk.3 However, treatment duration should never be based on pressure, stigma, or an arbitrary timeline. It should be based on clinical stability, recovery progress, cravings, relapse risk, mental health needs, and the person’s goals.
At Painted Grove Recovery, the clinical team helps patients understand each phase of Suboxone treatment. While some people eventually taper off medication, others may continue maintenance for longer when it supports safety and recovery.
Suboxone is one part of medication-assisted treatment, also called MAT or MOUD. While medication can reduce cravings and withdrawal symptoms, it works best when combined with therapy, structure, and practical recovery support.1 3
At Painted Grove Recovery in Louisville, KY, Suboxone may fit into treatment through three general phases:
Induction
Suboxone induction begins once mild-to-moderate withdrawal symptoms are present. Since timing is critical, medical staff help determine when it is appropriate to start medication. The goal during induction is to reduce withdrawal symptoms safely and begin stabilizing the body.
Stabilization
During stabilization, clinicians adjust medication based on symptoms and response. As cravings and withdrawal symptoms become more controlled, clients are often better able to participate in therapy, sleep more consistently, eat more regularly, and focus on treatment.
Maintenance
During Suboxone maintenance, medication continues alongside counseling and recovery support. This phase may include individual therapy, group therapy, relapse prevention planning, co-occurring mental health support, family involvement when appropriate, and aftercare planning.
Medication alone does not address every part of opioid addiction. Because opioid use disorder often affects coping skills, relationships, trauma, mental health, housing, employment, and daily routines, a full treatment program gives people support beyond symptom relief.
Painted Grove Recovery accepts Medicaid and supports adults in Louisville, Jefferson County, and throughout Kentucky who need medically supervised care for opioid addiction.
[H2] Managing Suboxone withdrawal and the tapering process
Some people eventually taper off Suboxone. Others stay on maintenance longer because it continues to support their recovery. Since both paths are valid when guided by clinical care, tapering should always be individualized.
Suboxone withdrawal may happen if the medication is stopped too quickly or discontinued without medical supervision. Although symptoms are often milder than withdrawal from heroin, fentanyl, or other full opioid agonists, they can still be uncomfortable.1
Possible Suboxone withdrawal symptoms may include:
A gradual taper gives the body more time to adjust. Because abrupt discontinuation increases the risk of relapse, patients should never stop Suboxone suddenly without medical guidance.
At Painted Grove Recovery, tapering is not treated as a race. The clinical team considers recovery stability, cravings, mental health symptoms, support systems, relapse history, and personal goals before making changes. If tapering becomes difficult, the plan can be adjusted.
The goal is not simply to stop taking medication. The goal is to protect recovery while helping each person move forward safely.
Suboxone is a medication used to treat opioid use disorder. It contains buprenorphine, which helps reduce cravings and withdrawal symptoms, and naloxone, which helps discourage misuse by injection.
Buprenorphine naloxone is the medication combination found in Suboxone. Buprenorphine is a partial opioid agonist, while naloxone is an opioid antagonist included as a misuse deterrent.
Suboxone side effects may include headache, nausea, constipation, sweating, insomnia, mouth numbness or irritation, and sleepiness. Serious side effects are possible, especially when Suboxone is mixed with alcohol, benzodiazepines, or other sedating substances. A prescribing clinician should review all risks and medications before treatment begins.
Suboxone induction is the first phase of treatment, when Suboxone is started after mild-to-moderate opioid withdrawal symptoms begin. Proper timing helps reduce the risk of precipitated withdrawal.
Suboxone contains buprenorphine, a partial opioid agonist, while methadone is a full opioid agonist. Both treat opioid use disorder, but they differ in how they work, how they are monitored, and where they are typically provided.
Suboxone contains buprenorphine and naloxone. Subutex contains buprenorphine only. Clinicians may recommend one over the other based on medical history, pregnancy status, naloxone sensitivity, induction needs, or other clinical factors.
Suboxone can cause withdrawal if it is started too soon after opioid use or stopped abruptly. When prescribed and tapered carefully, clinicians can reduce the risk and severity of withdrawal symptoms.
Suboxone treatment duration varies. Some people use it short-term during detox and stabilization, while others remain on maintenance longer. A clinician should individualize the timeline based on recovery progress, cravings, relapse risk, and treatment goals.
Painted Grove Recovery offers Suboxone treatment as part of medication-assisted treatment in Louisville, Kentucky. Call 502.842.4461 or reach out online to speak with the admissions team.
Sources:
If you are considering Suboxone treatment in Louisville, KY, Painted Grove Recovery is here to help you understand your options. Our Suboxone-integrated MAT program offers compassionate, medically supervised care for adults facing opioid use disorder.
Treatment may include:
Because recovery looks different for every person, our team creates treatment plans around each client’s symptoms, history, goals, and support needs. We also accept Medicaid, which helps make treatment more accessible for people across Louisville and Kentucky.
Call us today at 502.842.1425 or fill out a form to speak with our admissions team and learn how our Suboxone program can support your recovery journey.
You do not have to manage opioid withdrawal, cravings, or recovery decisions alone. Help is available, and treatment can begin with one conversation.
Courtney Hibbs is a behavioral health executive with over five years of experience in substance use and mental health treatment. As Chief Executive Officer, she brings a hands-on, people-centered leadership style focused on building strong teams, maintaining regulatory standards, and supporting accessible, high-quality care.
Her background includes executive and operational leadership within licensed treatment environments, with experience in program development, staffing, compliance, and organizational growth. Courtney has helped strengthen referral relationships, improve census and retention, and support service expansion through practical, engaged leadership.
Known for her ability to develop teams and lead through change, Courtney has rebuilt departments, implemented training programs, and mentored emerging leaders across multiple locations. She balances clear expectations with compassion, supporting both staff and the individuals they serve.
Courtney is deeply committed to ethical care and client advocacy. She believes well-run programs create the foundation for meaningful recovery and works closely with clinical, medical, and administrative teams to support safe, structured treatment experiences.
